ProstaLund Investor Relations Material
Latest events
Q4 2024
ProstaLund
Q1 2025
30 May, 2025
Q4 2024
20 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from ProstaLund
Access all reports
ProstaLund AB develops and sells urological devices for the treatment of patients with benign prostatic hyperplasia (BPH) internationally. The company offers BeeVital, a non-surgical therapy for BPH. It also provides Revive Flow, a laser treatment for neurogenic bladder; and Revive Basal, a drug for neurogenic bladder. The company distributes its products in the United States, Latin America, Canada, Europe, and Australia through specialized support centers. ProstaLund is hardquartered in Lund, Sweden.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
PLUN
Country
🇸🇪 Sweden